Trial Profile
Cholesterol lowerling effect of ezetimibe on hypercholesterolemic patients with type2 diabetes.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Feb 2011
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- 11 Sep 2009 New trial record